BioDelivery Sciences International Inc (NASDAQ:BDSI)
| 4.20 Data as of May 22 |  -0.14 / -3.23%Today’s Change | 3.12 Today|||52-Week Range 6.89 | -2.55% Year-to-Date |
Latest BDSI News | Press Releases
| BDSI Makes Notable Cross Below Critical Moving Average May 17 / TheStreet.com |
Today’s Trading
| Previous close | 4.34 |
| Today’s open | 4.29 |
| Day’s range | -- - -- |
| Volume | 332,828 |
| Average volume (3 months) | 220,658 |
| Market cap | $164.9M |
| Dividend yield | -- |
Data as of 4:00pm ET, 05/22/2013
Growth & Valuation
| Earnings growth (last year) | -- |
| Earnings growth (this year) | -2,111.43% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +1,571.58% |
| P/E ratio | NM |
| Price/Sales | 2.41 |
| Price/Book | 3.27 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| --Medytox Solutions In... | 0.00 | 0.00% |
| GERNGeron Corp | -0.02 | -1.79% |
| INOInovio Pharmaceutica... | -0.01 | -1.05% |
| TROVTrovagene Inc | -0.50 | -7.31% |
Data as of 4:00pm ET, 05/22/2013
Financials
| Next reporting date | August 9, 2013 |
| EPS forecast (this quarter) | -$0.35 |
| Annual revenue (last year) | $54.5M |
| Annual profit (last year) | $1.7M |
| Net profit margin | 3.03% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Other |
President, Chief Executive Officer & Director Mark A. Sirgo, PhD |
Chief Financial Officer, Secretary & Treasurer James A. McNulty, CPA |
Corporate headquarters Raleigh, North Carolina |
Forecasts
